ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization

Most breast cancer deaths occur in women with recurrent, estrogen receptor (ER)-α(+), metastatic tumors. There is a critical need for therapeutic approaches that include novel, targetable mechanism-based strategies by which ERα (+) tumors can be resensitized to endocrine therapies. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrobel, Kinga, Zhao, Yiru Chen, Kulkoyluoglu, Eylem, Chen, Karen Lee Ann, Hieronymi, Kadriye, Holloway, Jamie, Li, Sarah, Ray, Tania, Ray, Partha Sarathi, Landesman, Yosef, Lipka, Alexander Edward, Smith, Rebecca Lee, Madak-Erdogan, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045498/
https://www.ncbi.nlm.nih.gov/pubmed/27533791
http://dx.doi.org/10.1210/me.2016-1101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045498/
https://www.ncbi.nlm.nih.gov/pubmed/27533791
http://dx.doi.org/10.1210/me.2016-1101

Ejemplares similares